Barclays Maintains Overweight on Fortis, Lowers Price Target to $61

Benzinga Newsdesk www.benzinga.com Negative 87.4%

Neg 87.4% Neu 0% Pos 0%

Barclays analyst Michael Lonegan maintains Fortis (NYSE:FTS) with a Overweight and lowers the price target from $62 to $61.